ELDERMAFILL - Company finances
|
EUR
|
2023
From: 2023-03-09
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 73,670 | 195,696 | 214,870 |
| Profit before tax | 6,820 | 69,743 | 45,931 |
| Net profit | 5,787 | 66,288 | 43,086 |
| Equity | 8,287 | 74,575 | 117,661 |
| Liabilities | 74,610 | 65,315 | 10,345 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 82,897 | 139,759 | 127,842 |
| Total assets | 82,897 | 139,759 | 127,842 |
|
Taxes paid
|
|||
| STI taxes | 562 | 4,971 | 6,841 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +165.6% | +9.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.0% | 47.4% | 33.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 69.8% | 88.9% | 36.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.9% | 33.9% | 20.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.3% | 35.6% | 21.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 9.0 | 0.9 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 73,670 | 195,696 | 214,870 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ELDERMAFILL - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-12-18 | 2024-01-01 | 0.02 |
| 2023-11-16 | 2023-11-30 | 0.02 |
| 2023-10-27 | 2023-11-05 | 0.02 |
| 2023-10-25 | 2023-10-25 | 0.02 |
ELDERMAFILL - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ELDERMAFILL, UAB (code 306269409) is a private limited liability company engaged in the wholesale of perfume and cosmetics. In 2025, the company generated revenue of €214.9K, which was 9.8% higher year on year and 191.7% above the 2023 level. Net profit amounted to €43.1K, following €5.8K in 2023 and €66.3K in 2024, showing a strong rise over the period, although profit moderated in the latest year. The 2025 profit margin was 20.1%. At year end, total assets stood at €127.8K, equity at €117.7K and liabilities at €10.3K. The balance sheet was therefore strongly equity-funded, with an equity ratio of 92.0% and a debt-to-equity ratio of 0.09. Return on equity was 36.6%, return on assets 33.7% and asset turnover 1.68x. Revenue per employee was €214.9K and profit per employee was €43.1K, indicating solid productivity in 2025.